E1 initial reporter phone: (b)(6).Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device 31056112l number, and no internal action related to the complaint was found during the review.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
It was reported that a patient underwent cardiac ablation procedure that included thermocool smarttouch sf catheter.The patient experienced heart block that required surgical intervention.Timing: after ablating the at and stopping the at.Description of health hazard: heart block; autologous pulse was stopped.The power supply setting was 40w, imp cut off 220o, and ablation catheter temperature was 30°c.Autologous pulse wasn't restored.Temporary pacemaker was inserted.Temporary pacemaker was inserted and the patient returned to the room.The physician determined that the patient might have sick sinus syndrome from the beginning and that there was a high possibility of a procedural error.Physician assessment of the health problem: non-serious (moderate/minor).Method of cf monitoring --- real time graph; vector; visitag.No abnormalities observed prior or during the use of the product.Additional event information: the medical team decided to implant a pacemaker to the patient.The adverse event occurred during use of bwi products.There was a possibility of sick sinus syndrome ordinally and that there was a high possibility of a procedural error.No further information currently available.Carto3 ver.7.2.40.250 since the event is life threatening and it might result in permanent impairment of a body function or permanent damage to a body structure; or it could require medical or surgical intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious.
|
On 16-aug-2023, bwi received additional information indicating that the patient fully recovered.The patient did not require extended hospitalization.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|